WRAP North America

计划入组 250 人 · 首次发布于 2025 年 2 月 4 日

Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)

计划入组 500 人 · 首次发布于 2021 年 9 月 30 日

The Merit WRAPSODY Central Feasibility Study

首次发布于 2020 年 9 月 9 日

Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)

Anti-EPCAM CAR-T cell therapy (Sinobioway)

autologous stem cell therapy

Gamida Cell

Israel

GAMIDA CELL INC.

United States

CELL GENESYS INC.

United States

Merit Medical's WRAPSODY Endoprosthesis Receives FDA Approval for Dialysis Patients

Merit Medical Enrolls First Patient in WRAPSODY Registry for Hemodialysis Vascular Access

Merit Medical's WRAPSODY Stent Graft Shows Promise in Dialysis Access